Wireless device for precise brain stimulation
Sub-millimeter precision wireless neuromodulation using a microwave split ring resonator
This study is exploring a new, gentle way to stimulate the brain using a wireless device that uses microwave technology, which could help improve treatments for people with brain injuries by targeting specific areas without harming nearby tissues.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10892823 on NIH RePORTER |
What this research studies
This research investigates a new method for minimally invasive brain stimulation using a wireless device that employs microwave technology. The device is designed to target specific areas of the brain with high precision, potentially allowing for better treatment of conditions like acquired brain injuries. By using a microwave split ring resonator, the researchers aim to create localized electrical fields that can modulate neural activity without damaging surrounding tissues. This approach could lead to advancements in how neurological conditions are treated, providing a more effective option for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with acquired brain injuries or other neurological disorders that could benefit from targeted neuromodulation.
Not a fit: Patients with conditions unrelated to brain function or those who do not have access to the required technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with brain injuries and other neurological conditions.
How similar studies have performed: While the use of microwave technology for neuromodulation is relatively novel, similar approaches in other forms of electromagnetic stimulation have shown promise in preliminary studies.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Cheng, Ji-Xin — Boston University (Charles River Campus)
- Study coordinator: Cheng, Ji-Xin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.